A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 18,086 shares of NVO stock, worth $1.58 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
18,086
Previous 17,261 4.78%
Holding current value
$1.58 Million
Previous $2.46 Million 12.59%
% of portfolio
0.09%
Previous 0.11%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$119.07 - $145.42 $98,232 - $119,971
825 Added 4.78%
18,086 $2.15 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $71,785 - $85,942
-585 Reduced 3.28%
17,261 $2.46 Million
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $315,622 - $420,128
3,091 Added 20.95%
17,846 $2.29 Million
Q4 2023

Jan 30, 2024

SELL
$87.78 - $105.45 $49,771 - $59,790
-567 Reduced 3.7%
14,755 $1.53 Million
Q3 2023

Oct 17, 2023

BUY
$90.94 - $199.54 $696,691 - $1.53 Million
7,661 Added 100.0%
15,322 $1.39 Million
Q2 2023

Jul 19, 2023

SELL
$155.98 - $172.65 $6,863 - $7,596
-44 Reduced 0.57%
7,661 $1.24 Million
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $50,686 - $60,950
383 Added 5.23%
7,705 $1.23 Million
Q3 2022

Oct 26, 2022

BUY
$95.28 - $116.93 $8,098 - $9,939
85 Added 1.17%
7,322 $729,000
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $43,012 - $51,993
-462 Reduced 6.0%
7,237 $802,000
Q2 2021

Jul 27, 2021

SELL
$67.66 - $84.76 $47,767 - $59,840
-706 Reduced 8.4%
7,699 $644,000
Q4 2020

Feb 09, 2021

BUY
$63.89 - $73.8 $228,917 - $264,425
3,583 Added 74.31%
8,405 $587,000
Q3 2020

Oct 20, 2020

SELL
$63.69 - $70.22 $213,679 - $235,588
-3,355 Reduced 41.03%
4,822 $334,000
Q2 2020

Jul 02, 2020

SELL
$58.54 - $67.94 $341,405 - $396,226
-5,832 Reduced 41.63%
8,177 $535,000
Q1 2020

Apr 01, 2020

SELL
$49.46 - $64.78 $122,561 - $160,524
-2,478 Reduced 15.03%
14,009 $843,000
Q3 2019

Oct 09, 2019

BUY
$47.54 - $53.43 $808 - $908
17 Added 0.1%
16,487 $852,000
Q2 2018

Aug 16, 2018

SELL
$44.29 - $50.42 $4,429 - $5,042
-100 Reduced 0.6%
16,470 $760,000
Q1 2018

May 15, 2018

SELL
$48.49 - $58.14 $154,101 - $184,768
-3,178 Reduced 16.09%
16,570 $816,000
Q4 2017

Feb 08, 2018

BUY
$47.53 - $53.73 $762,333 - $861,775
16,039 Added 432.43%
19,748 $1.06 Million
Q2 2017

Aug 15, 2017

BUY
N/A
3,709
3,709 $159,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.